Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 AIDS-related malignancies.

Literature DB >> 12044013

AIDS-related malignancies.

Abstract

Cancer remains a significant burden for human immunodeficiency virus (HIV)-infected individuals. Most cancers that are associated with HIV infection are driven by oncogenic viruses, such as Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus and human papillomavirus. Gaining insight into the epidemiology and mechanisms that underlie AIDS-related cancers has provided us with a better understanding of cancer immunity and viral oncogenesis.

Entities: Disease Species

Mesh：

Year: 2002 PMID： 12044013 DOI： 10.1038/nrc797

Source DB: PubMed Journal: Nat Rev Cancer ISSN： 1474-175X Impact factor: 60.716

Keyword Cloud
Cited

101 in total

1. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

Authors: Thomas S Uldrick; Victoria Wang; Deirdre O'Mahony; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Seth M Steinberg; Stefania Pittaluga; Irina Maric; Denise Whitby; Giovanna Tosato; Richard F Little; Robert Yarchoan
Journal: Clin Infect Dis Date: 2010-08-01 Impact factor: 9.079

Review 2. Kaposi's sarcoma and its associated herpesvirus.

Authors: Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal: Nat Rev Cancer Date: 2010-10 Impact factor: 60.716

Review 3. Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors: Lingyun Geng; Xin Wang
Journal: Int J Clin Exp Med Date: 2015-09-15

4. CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.

Authors: Kavya Rakhra; Pavan Bachireddy; Tahera Zabuawala; Robert Zeiser; Liwen Xu; Andrew Kopelman; Alice C Fan; Qiwei Yang; Lior Braunstein; Erika Crosby; Sandra Ryeom; Dean W Felsher
Journal: Cancer Cell Date: 2010-10-28 Impact factor: 31.743

5. Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.

Authors: Mandana Mansouri; Janet Douglas; Patrick P Rose; Kristine Gouveia; Gary Thomas; Robert E Means; Ashlee V Moses; Klaus Früh
Journal: Blood Date: 2006-04-06 Impact factor: 22.113

6. Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.

Authors: Danyang Gong; Xinghong Dai; Yuchen Xiao; Yushen Du; Travis J Chapa; Jeffrey R Johnson; Xinmin Li; Nevan J Krogan; Hongyu Deng; Ting-Ting Wu; Ren Sun
Journal: J Virol Date: 2017-07-12 Impact factor: 5.103

AIDS-related malignancies.

1. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

Review 2. Kaposi's sarcoma and its associated herpesvirus.

Review 3. Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

4. CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.

5. Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.

6. Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.

7. LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.

Review 8. Lymphocytes in cancer development: polarization towards pro-tumor immunity.

Review 9. Immune escape by Epstein-Barr virus associated malignancies.

10. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming.